Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Cauli

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Autoimmunity Reviews|March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensusFabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.
Frontiers in Pharmacology|May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Arthritis Research & Therapy|September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohortRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Rheumatology (Oxford, England)|April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritisGiuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
The Journal of Rheumatology|July 1, 2024
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter StudyChiara Tani, Chiara Cardelli, Margherita Zen, et al.
The Journal of Rheumatology|May 3, 2017
Proceedings of the GRAPPA 2016 RetreatDeepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
The Journal of Rheumatology|May 5, 2007
Consensus on a core set of domains for psoriatic arthritisDafna D Gladman, Philip J Mease, Vibeke Strand, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trialRosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Autoimmunity Reviews|March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensusFabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.
Frontiers in Pharmacology|May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Arthritis Research & Therapy|September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohortRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Rheumatology (Oxford, England)|April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritisGiuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
The Journal of Rheumatology|July 1, 2024
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter StudyChiara Tani, Chiara Cardelli, Margherita Zen, et al.
The Journal of Rheumatology|May 3, 2017
Proceedings of the GRAPPA 2016 RetreatDeepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
The Journal of Rheumatology|May 5, 2007
Consensus on a core set of domains for psoriatic arthritisDafna D Gladman, Philip J Mease, Vibeke Strand, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trialRosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Pageof 18